Scarica l'app Stockscreener
2.97
1.66%
-0.05
Dopo l'orario di chiusura:
2.97
Precedente Chiudi:
$3.02
Aprire:
$3.01
Volume 24 ore:
39,116
Relative Volume:
0.85
Capitalizzazione di mercato:
$132.74M
Reddito:
$11.51M
Utile/perdita netta:
$-101.84M
Rapporto P/E:
-1.1118
EPS:
-2.6714
Flusso di cassa netto:
$-82.98M
1 W Prestazione:
+10.00%
1M Prestazione:
-1.00%
6M Prestazione:
-36.94%
1 anno Prestazione:
-61.13%
Intervallo 1D:
$2.93
$3.01
Intervallo di 1 settimana:
$2.81
$3.06
Portata 52W:
$2.68
$8.5878
Nyxoah Sa Stock (NYXH) Company Profile
Nome
Nyxoah Sa
Settore
Industria
Telefono
-
Indirizzo
-
Compare NYXH vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
2.97 | 134.98M | 11.51M | -101.84M | -82.98M | -2.6714 |
ISRG
Intuitive Surgical Inc
|
402.30 | 146.01B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.43 | 40.04B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
64.28 | 32.04B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
33.19 | 30.23B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
182.82 | 27.04B | 5.54B | 1.52B | 1.74B | 10.37 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-07-31 | Iniziato | H.C. Wainwright | Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2022-04-21 | Iniziato | Oppenheimer | Outperform |
| 2022-04-06 | Iniziato | Wolfe Research | Peer Perform |
| 2021-12-21 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-07-28 | Iniziato | Cantor Fitzgerald | Overweight |
Mostra tutto
Nyxoah Sa Borsa (NYXH) Ultime notizie
Nyxoah (NYXH) Slips 5.9% as Shares Test Support Near $2.56Factor Momentum - thelegaladvocate.com
Nyxoah (NYXH) Q1 2026 Earnings: Narrower-Than-Expected Loss as Pre-Revenue Biotech Advances Sleep Apnea PipelineEarnings Trend Analysis - thelegaladvocate.com
Nyxoah SA (NYXH) Q1 2026 Earnings: Narrower-Than-Expected Loss as Company Advances Sleep Apnea PlatformProfitability Analysis - thelegaladvocate.com
Nyxoah Q1 earnings call highlights - MSN
Nyxoah SA Q1 2026 Earnings: Narrower-Than-Expected Loss on Operational DisciplineEstimate Dispersion - thelegaladvocate.com
Nyxoah Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Continued ProgressFinal Results - Newser
Nyxoah SA (NYXH) Stock Analysis: Flat at $2.90, What's Next 2026-05-21Linear Regression - Newser
Nyxoah SA (NYXH) Delivers Q1 2026 Beat — EPS $-0.37 vs $-0.51 ExpectedTrending Volume Leaders - Newser
Nyxoah details 44.7m voting shares, up to 8.6m via bonds - Stock Titan
Nyxoah Welcomes the Flemish Investors Federation (VFB) at - GlobeNewswire
Nyxoah SA Earnings Call Highlights Growth And Strain - TipRanks
Nyxoah SA (NYXH) Fell -3.92% — Is a Recovery Ahead? 2026-05-19Bear Flag - Newser
Nyxoah SA (NYXH) Stock: Slides -4.10%, Support at $2.67 2026-05-19Composite Profile - Newser
Analysts Are Upgrading Nyxoah SA (EBR:NYXH) After Its Latest Results - simplywall.st
Nyxoah SAOrdinary Shares (NQ: NYXH - FinancialContent
Earnings call transcript: Nyxoah Q1 2026 sees strong U.S. growth, stock dips - Investing.com Nigeria
Transcript : Nyxoah SA Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 05 - marketscreener.com
NYXH: Rapid U.S. commercialization and strong clinical results drive growth in sleep apnea neuromodulation - TradingView
Nyxoah Earnings Call: Growth Surges Amid Cash Strain - TipRanks
Piper Sandler cuts Nyxoah stock price target on balance sheet concerns - Investing.com UK
Piper Sandler cuts Nyxoah stock price target on balance sheet concerns By Investing.com - Investing.com India
This Toast Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Sahm
Nyxoah SA Stock 12‑Month Price Target Cut to $9.16, Implies 198% Upside - TradingView
Nyxoah S.A. (NASDAQ:NYXH) Q1 2026 Earnings Call Transcript - Insider Monkey
Nyxoah SA Stock 12‑Month Price Target Cut to $9.19, Implies 199% Upside - TradingView
Earnings Call Summary | Nyxoah SA(NYXH.US) Q1 2026 Earnings Conference - Moomoo
Nyxoah SA (NYXH) reports Q1 loss, tops revenue estimates - MSN
Nyxoah Q1 Earnings Call Highlights - sharewise.com
Nyxoah SA reports results for the quarter ended March 31Earnings Summary - TradingView
Nyxoah SA (NYXH) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: Nyxoah Q1 2026 sees strong U.S. growth, stock dips By Investing.com - Investing.com South Africa
Nyxoah Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Nyxoah Calls June 10 Shareholder Meetings and Files Q1 2026 Results - TipRanks
Nyxoah Reports First Quarter 2026 Financial and Operating Results - The Manila Times
NYXH: Q1 2026 net revenue rose to €6.4M, driven by U.S. Genio launch and robust reimbursement - TradingView
Nyxoah (Nasdaq: NYXH) posts Q1 2026 surge in revenue but flags funding risk - Stock Titan
Nyxoah : Q1 Report 2026 - marketscreener.com
Stifel cuts Nyxoah stock rating on reimbursement challenges By Investing.com - Investing.com Australia
Stifel cuts Nyxoah stock rating on reimbursement challenges - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $10 - Moomoo
Nyxoah to let registered holders follow June 10 meetings by video - Stock Titan
Invitation to attend the annual and the extraordinary - GlobeNewswire
MSN - MSN
Earnings Preview: Nyxoah SA to Report Financial Results on May 12 - 富途牛牛
What makes Nyxoah SA (NYXH) a safer bet than newer entrants (-0.62%) 2026-05-07Investment Picks - Newser
Nyxoah Sa Azioni (NYXH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.52%
1.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):